Determinants of meconium-stained amniotic fluid among women delivered at southwestern referral hospitals, Southwest Ethiopia: a multi-center case-control study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 07 08 2024
accepted: 26 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Meconium-stained amniotic fluid (MSAF) is a condition in which meconium is present in the uterus during ante-natal and complicates 10-15% of all live births. Scanty information is known about the determinants of meconium-stained amniotic fluid. Hence, this study aimed to identify determinants of meconium-stained amniotic fluid among women delivered at southwestern referral hospitals in southwest Ethiopia, in 2024. An institutional-based case-control study was employed from January 1, 2024, to June 30, 2024. The study was conducted in four southwestern referral hospitals in southwest Ethiopia. The final sample size includes 321(107 cases and 214 controls). The sample size was proportionally allocated for cases and controls for each referral hospital. Simple random sampling was used to select patient charts and data was collected from the chart using questions/tools developed after reviewing relevant literature. Data were entered using Epi-data version 3.1 and analyzed using SPSS version 25. Data was analyzed using binary logistic regression. All independent variables with P- the value of < 0.25 in univariable analysis were considered for multivariable logistic regression. Determinant factors of meconium-stained amniotic fluid were identified at a 95% confidence interval with a p-value < 0.05 was utilized to declare statistical significance. A total of 107 cases and 214 controls were included in this study. The finding from this study stated that induction of labor [AOR = 2.37, 95% CI = 1.28-8.89], obstructed labor [AOR = 2.62, 95%CI = 1.1-6.79], duration of labor greater than 24 h [AOR = 2.8, 95% CI = 1.55-15.44], and premature rupture of the membrane [AOR = 2.98, 95%CI = 1.1-8.23] were found to be significantly associated with meconium-stained amniotic fluid. Conclusively, a mother with induced or obstructed labor, labor duration greater than 24 h, and premature rupture of membrane need special attention during delivery care to reduce potential risk factors to feto-maternal outcomes related to meconium-stained amniotic fluid.

Sections du résumé

BACKGROUND BACKGROUND
Meconium-stained amniotic fluid (MSAF) is a condition in which meconium is present in the uterus during ante-natal and complicates 10-15% of all live births. Scanty information is known about the determinants of meconium-stained amniotic fluid. Hence, this study aimed to identify determinants of meconium-stained amniotic fluid among women delivered at southwestern referral hospitals in southwest Ethiopia, in 2024.
METHODS METHODS
An institutional-based case-control study was employed from January 1, 2024, to June 30, 2024. The study was conducted in four southwestern referral hospitals in southwest Ethiopia. The final sample size includes 321(107 cases and 214 controls). The sample size was proportionally allocated for cases and controls for each referral hospital. Simple random sampling was used to select patient charts and data was collected from the chart using questions/tools developed after reviewing relevant literature. Data were entered using Epi-data version 3.1 and analyzed using SPSS version 25. Data was analyzed using binary logistic regression. All independent variables with P- the value of < 0.25 in univariable analysis were considered for multivariable logistic regression. Determinant factors of meconium-stained amniotic fluid were identified at a 95% confidence interval with a p-value < 0.05 was utilized to declare statistical significance.
RESULTS RESULTS
A total of 107 cases and 214 controls were included in this study. The finding from this study stated that induction of labor [AOR = 2.37, 95% CI = 1.28-8.89], obstructed labor [AOR = 2.62, 95%CI = 1.1-6.79], duration of labor greater than 24 h [AOR = 2.8, 95% CI = 1.55-15.44], and premature rupture of the membrane [AOR = 2.98, 95%CI = 1.1-8.23] were found to be significantly associated with meconium-stained amniotic fluid.
CONCLUSION CONCLUSIONS
Conclusively, a mother with induced or obstructed labor, labor duration greater than 24 h, and premature rupture of membrane need special attention during delivery care to reduce potential risk factors to feto-maternal outcomes related to meconium-stained amniotic fluid.

Identifiants

pubmed: 39402457
doi: 10.1186/s12884-024-06867-4
pii: 10.1186/s12884-024-06867-4
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

672

Informations de copyright

© 2024. The Author(s).

Références

Mazor M, Hershkovitz R, Bashiri A, Maymon E, Schreiber R, Dukler D, Katz M, Shoham-Vardi I. Meconium stained amniotic fluid in preterm delivery is an independent risk factor for perinatal complications. Eur J Obstet Gynecol Reproductive Biology. 1998;81(1):9–13.
doi: 10.1016/S0301-2115(98)00141-9
Hailemariam HA, Nigusse FG, Gamshe EN. Prevalence and contributing factors of meconium stained amniotic fluid among women delivered at St Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. J Med Physiol Biophys. 2020;67:1–6.ISSN 2422-8427.
Tolu LB, Birara M, Teshome T, Feyissa GT. Perinatal outcome of meconium-stained amniotic fluid among laboring mothers at teaching referral hospital in urban Ethiopia. PLoS ONE. 2020;15(11):e0242025.
doi: 10.1371/journal.pone.0242025 pubmed: 33186362 pmcid: 7665744
Shrestha A, Singh SD, Tamrakar D. Associated factors and outcome of babies born through meconium-stained amniotic fluid. Kathmandu Univ Med J. 2018;16(61):65–8.
Gupta V, Bhatia BD, Mishra OP. Meconium stained amniotic fluid: antenatal, intrapartum and neonatal attributes. Indian Pediatr. 1996;33:293–8.
pubmed: 8772903
Swain P, Thapalial A. Meconium stained amniotic fluid–a potential predictor of meconium aspiration syndrome. J Nepal Pediatr Soc. 2008;28(1):3–6.
doi: 10.3126/jnps.v28i1.1397
Fischer C, Rybakowski C, Ferdynus C, Sagot P, Gouyon JB. A population-based study of meconium aspiration syndrome in neonates born between 37 and 43 weeks of gestation. Int J Pediatr. 2012;2012(1):321545.
pubmed: 22187569
Sundaram R, Murugesan A. Risk factors for meconium-stained amniotic fluid and its implications. Int J Reprod Contracept Obstet Gynecol. 2016;5(8):2503–6.
doi: 10.18203/2320-1770.ijrcog20162247
Maymon E, Chaim W, Furman B, Ghezzi F, Vardi IS, Mazor M. Meconium stained amniotic fluid in very low-risk pregnancies at term gestation. Eur J Obstet Gynecol Reproductive Biology. 1998;80(2):169–73.
doi: 10.1016/S0301-2115(98)00122-5
Gallo DM, Romero R, Bosco M, Gotsch F, Jaiman S, Jung E, Suksai M, y, Cajal CL, Yoon BH, Chaiworapongsa T. Meconium-stained amniotic fluid. American journal of obstetrics and gynecology. 2023;228(5):S1158-78.
Fang ZJ, Liu HF, Zhang YL, Yu L, Yan JY. Relation of meconium-stained amniotic fluid and postpartum hemorrhage: a retrospective cohort study. Eur Rev Med Pharmacol Sci. 2020;24(20).
Addisu D, Asres A, Gedefaw G, Asmer S. Prevalence of meconium-stained amniotic fluid and its associated factors among women who gave birth at term in Felege Hiwot comprehensive specialized referral hospital, North West Ethiopia: a facility based cross-sectional study. BMC Pregnancy Childbirth. 2018;18:1–7.
doi: 10.1186/s12884-018-2056-y
Gebregziabher GT, Hadgu FB, Abebe HT. Prevalence and associated factors of perinatal asphyxia in neonates admitted to Ayder Comprehensive Specialized Hospital, Northern Ethiopia: a cross-sectional study. Int J Pediatr. 2020;2020(1):4367248.
pubmed: 32110243 pmcid: 7042545
Gauchan E, Basnet S, Malla T. Meconium aspiration syndrome and neonatal outcome: a prospective study. Am J Public Health Res. 2015;3(5A):48–52.
Patel S, Patel B, Shah A, Jani S, Jani C. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Indian J Obstet Gynecol Res. 2020;4.
Nirmala C, Thomas L, Sujatha Y. Risk factors of meconium-stained amniotic fluid-a case-control study. Int J Clin Obstet Gynecol. 2020;4(2):157–60.
doi: 10.33545/gynae.2020.v4.i2c.521
Osava RH, Silva FM, Oliveira SM, Tuesta EF, Amaral MC. Meconium-stained amniotic fluid and maternal and neonatal factors associated. Rev Saude Publica. 2013;46:1023–9.
doi: 10.1590/S0034-89102013005000005
Tybulewicz AT, Clegg SK, Fonfé GJ, Stenson BJ. Preterm meconium staining of the amniotic fluid: associated findings and risk of adverse clinical outcome. Archives Disease Childhood-Fetal Neonatal Ed. 2004;89(4):F328–30.
doi: 10.1136/adc.2002.021949
Rao KS, Pathapati S, Vansipriya C. Risk factors for meconium stained liquor and outcome of neonate in meconium stained amniotic fluid. Indian J Obstet Gynecol Res. 2021;4(1):1–5.
Mehar V, Agarwal N, Agarwal A, Agarwal S, Dubey N, Kumawat H. Meconium-stained amniotic fluid as a potential risk factor for perinatal asphyxia: a single-center experience. J Clin Neonatology. 2016;5(3):157–61.
doi: 10.4103/2249-4847.191246
Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during ten years. J Perinatol. 2009;29(7):497–503.
doi: 10.1038/jp.2008.241 pubmed: 19158800
Khazardoost S, Hantoushzadeh S, Khooshideh M, Borna S. Risk factors for meconium aspiration in meconium stained amniotic fluid. J Obstet Gynaecol. 2007;27(6):577–9.
doi: 10.1080/01443610701469636 pubmed: 17896254
Tayade S. The significance of the meconium-stained amniotic fluid cross-sectional study in a rural setup. IJBAR. 2012;3(12):861–66.
Ward C, Caughey AB. The risk of meconium aspiration syndrome (MAS) increases with gestational age at term. J Maternal-Fetal Neonatal Med. 2022;35(1):155–60.
doi: 10.1080/14767058.2020.1713744
Espinheira MC, Grilo M, Rocha G, Guedes B, Guimaraes H. Meconium aspiration syndrome-the experience of a tertiary center. Revista Portuguesa De Pneumologia (English Edition). 2011;17(2):71–6.
doi: 10.1016/S2173-5115(11)70017-3
Pariente G, Peles C, Perri ZH, Baumfeld Y, Mastrolia SA, Koifman A, Weintraub AY, Hershkovitz R. Meconium-stained amniotic fluid–risk factors and immediate perinatal outcomes among SGA infants. J Maternal-Fetal Neonatal Med. 2015;28(9):1064–7.
doi: 10.3109/14767058.2014.942634
Wiswell TE, Bent RC. Meconium staining and the meconium aspiration syndrome: unresolved issues. Pediatr Clin North Am. 1993;40(5):955–81.
doi: 10.1016/S0031-3955(16)38618-7 pubmed: 8414717
Arif H, Ikram N, Riaz S, Arif AN, Ikram N, Riaz S, Nafisa A. Risk factors and outcome of neonatal thrombocytopenia. J Rawalpindi Med Coll. 2020;24(3).
Uvnäs-Moberg K, Ekström-Bergström A, Berg M, Buckley S, Pajalic Z, Hadjigeorgiou E, Kotłowska A, Lengler L, Kielbratowska B, Leon-Larios F, Magistretti CM. Maternal plasma levels of oxytocin during physiological childbirth–a systematic review with implications for uterine contractions and central actions of oxytocin. BMC Pregnancy Childbirth. 2019;19:1–7.
doi: 10.1186/s12884-019-2365-9
Sori D, Belete A, Wolde M. Meconium stained amniotic fluid: factors affecting maternal and perinatal outcomes at Jimma University specialized teaching hospital, South West Ethiopia. Gynecol Obstet (Sunnyvale). 2016;6(394):2161–0932.
Dugas MA, Proulx F, de Jaeger A, Lacroix J, Lambert M. Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med. 2000;26:75–83.
doi: 10.1007/s001340050015 pubmed: 10663284 pmcid: 7095440
Assefa NE, Berhe H, Girma F, Berhe K, Berhe YZ, Gebreheat G, Werid WM, Berhe A, Rufae HB, Welu G. Risk factors of premature rupture of membranes in public hospitals at Mekele City, Tigray, a case-control study. BMC Pregnancy Childbirth. 2018;18:1–7.

Auteurs

Rebuma Sorsa (R)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia. rebumasorsa998@gmail.com.

Tesfaye Adugna (T)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Kumsa Kene (K)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Deriba Abera (D)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Diriba Dereje (D)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Bati Leta (B)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Hawi Gobena (H)

Department of Nursing, Institute of Health, Faculty of Health Sciences, Jimma University, Jimma, Ethiopia.

Diriba Sufa (D)

Public Health Institute (EPHI) center for public health and emergency management, Addis Ababa, Ethiopia.

Urge Gerema (U)

Department of Biomedical Sciences, Institute of Health, Faculty of Medical Sciences, Jimma University, Jimma, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH